etretinate - CISMeF

Preferred Label : etretinate;

MeSH definition : An oral retinoid used in the treatment of keratotic genodermatosis, lichen planus, and psoriasis. Beneficial effects have also been claimed in the prophylaxis of epithelial neoplasia. The compound may be teratogenic.;

MeSH synonym : ethyl etrinoate; etrinoate, ethyl;

MeSH hyponym : ro 10-9359; B10-9359; tigason; Tigazon; B10 9359; B109359; Ro 109359; Ro-10-9359; Ro 10 9359; Ro109359;

MeSH CAS label : 2,4,6,8-Nonatetraenoic acid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, ethyl ester, (all-E)-;

MeSH Related Number : 54350-48-0 (Etretinate);

Registry Number MeSH : 54350-48-0;

Codes EINECS : 259-119-3;

Is substance : O;

UNII : 65M2UDR9AG;

InChIKey : HQMNCQVAMBCHCO-DJRRULDNSA-N;

Détails

Origin ID

D005050;

UMLS CUI

C0015137;

ATC code(s)
- etretinate [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- etretinate [Substance BNPC]
Currated CISMeF NLP mapping
- Acitretin [NCIt concept]
- Etretinate [ICD-11 Extension code]
- Etretinate [NCIt concept]
- Etretinate (substance) [SNOMED CT concept]
- Product containing etretinate (medicinal product) [SNOMED CT concept]
- etretin [Substance BNPC]
Pharmacological action(s)
- keratolytic agents [MeSH Descriptor]
Record concept(s)
- B10-9359 [MeSH concept]
- etretinate [MeSH concept]
- ro 10-9359 [MeSH concept]
- tigason [MeSH concept]
Related MeSH Supplementary Concept(s)
- 4-hydroxyetretinate [MeSH Supplementary Concept]
- BCPE protocol [MeSH Supplementary Concept]
- ro 12-7310 [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Etretinate [ICD-11 Extension code]
- Etretinate [NCIt concept]
- Etretinate (substance) [SNOMED CT concept]
- Product containing etretinate (medicinal product) [SNOMED CT concept]
- etretinate [ATC Code]
- etretinate [Substance BNPC]
Validated automatic mappings to BTNT
- etretinate [ATC Code]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients